Human Phenotype Ontology 
Grandparent Node:
expand
Growth abnormality (HP:0001507)help
Parent Node:
expand
Abnormality of body weight (HP:0004323)help
..Starting node
..expand
Abnormality of body mass index (HP:0045081)help
Term ID: 45081
Name: Abnormality of body mass index
Synonym: Abnormal BMI; Abnormal body mass index
Definition: Anomaly in the weight-to-height squared ratio, calculated by dividing the individual's weight in kilograms by the square of the individual's height in meters and used as an indicator of obesity and underweight compared to averages.
Comments:
Reference: HP:0045081
Genes and Diseases:
 
       Child Nodes:
........expandIncreased body mass index (HP:0031418) help
........expandDecreased body mass index (HP:0045082) help

 Sister Nodes: 
..expandAbnormal waist to hip ratio (HP:0031818) help
..expandDecreased body weight (HP:0004325) help
..expandIncreased body weight (HP:0004324) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0045081HP:0045081Abnormality of body mass index0CEACAM3 CL E G H10841815ORPHA:586Cystic fibrosis
HP:0045081HP:0045081Abnormality of body mass index0CEACAM6 CL E G H46801818ORPHA:586Cystic fibrosis1
HP:0045081HP:0045081Abnormality of body mass index0CFTR CL E G H10801884ORPHA:586Cystic fibrosis1371
HP:0045081HP:0045081Abnormality of body mass index0CLCA4 CL E G H228022018ORPHA:586Cystic fibrosis
HP:0045081HP:0045081Abnormality of body mass index0CORIN CL E G H1069919012ORPHA:275555Preeclampsia5
HP:0045081HP:0045081Abnormality of body mass index0DCTN4 CL E G H5116415518ORPHA:586Cystic fibrosis
HP:0045081HP:0045081Abnormality of body mass index0EDNRA CL E G H19093179ORPHA:586Cystic fibrosis3
HP:0045081HP:0045081Abnormality of body mass index0FLT1 CL E G H23213763ORPHA:275555Preeclampsia11
HP:0045081HP:0045081Abnormality of body mass index0GCLC CL E G H27294311ORPHA:586Cystic fibrosis2
HP:0045081HP:0045081Abnormality of body mass index0GSTM3 CL E G H29474635ORPHA:586Cystic fibrosis1
HP:0045081HP:0045081Abnormality of body mass index0HFE CL E G H30774886ORPHA:586Cystic fibrosis38
HP:0045081HP:0045081Abnormality of body mass index0HMOX1 CL E G H31625013ORPHA:586Cystic fibrosis3
HP:0045081HP:0045081Abnormality of body mass index0HTT CL E G H30644851ORPHA:399Huntington disease12
HP:0045081HP:0045081Abnormality of body mass index0KCNN4 CL E G H37836293ORPHA:586Cystic fibrosis3
HP:0045081HP:0045081Abnormality of body mass index0MIF CL E G H42827097ORPHA:586Cystic fibrosis1
HP:0045081HP:0045081Abnormality of body mass index0SERPINA1 CL E G H52658941ORPHA:586Cystic fibrosis131
HP:0045081HP:0045081Abnormality of body mass index0SLC11A1 CL E G H655610907ORPHA:586Cystic fibrosis2
HP:0045081HP:0045081Abnormality of body mass index0SLC16A2 CL E G H656710923ORPHA:59Allan-Herndon-Dudley syndrome57
HP:0045081HP:0045081Abnormality of body mass index0SLC25A13 CL E G H1016510983ORPHA:247585Citrullinemia type II82
HP:0045081HP:0045081Abnormality of body mass index0SLC26A9 CL E G H11501914469ORPHA:586Cystic fibrosis5
HP:0045081HP:0045081Abnormality of body mass index0SLC2A3 CL E G H651511007ORPHA:399Huntington disease1
HP:0045081HP:0045081Abnormality of body mass index0SLC6A14 CL E G H1125411047ORPHA:586Cystic fibrosis
HP:0045081HP:0045081Abnormality of body mass index0SLC9A3 CL E G H655011073ORPHA:586Cystic fibrosis7
HP:0045081HP:0045081Abnormality of body mass index0STOX1 CL E G H21973623508ORPHA:275555Preeclampsia2
HP:0045081HP:0045081Abnormality of body mass index0STX1A CL E G H680411433ORPHA:586Cystic fibrosis
HP:0045081HP:0045081Abnormality of body mass index0TGFB1 CL E G H704011766ORPHA:586Cystic fibrosis13
HP:0045081HP:0045081Abnormality of body mass index0THOC2 CL E G H5718719073OMIM:300957Mental retardation, X-linked 12/355
HP:0045081HP:0045081Abnormality of body mass index0THRA CL E G H706711796OMIM:614450Hypothyroidism, congenital, nongoitrous, 69
HP:0045081HP:0045082Decreased body mass index1CEACAM3 CL E G H10841815ORPHA:586Cystic fibrosis
HP:0045081HP:0045082Decreased body mass index1CEACAM6 CL E G H46801818ORPHA:586Cystic fibrosis1
HP:0045081HP:0045082Decreased body mass index1CFTR CL E G H10801884ORPHA:586Cystic fibrosis1371
HP:0045081HP:0045082Decreased body mass index1CLCA4 CL E G H228022018ORPHA:586Cystic fibrosis
HP:0045081HP:0031418Increased body mass index1CORIN CL E G H1069919012ORPHA:275555PreeclampsiaHP:0040283 - Occasional5
HP:0045081HP:0045082Decreased body mass index1DCTN4 CL E G H5116415518ORPHA:586Cystic fibrosis
HP:0045081HP:0045082Decreased body mass index1EDNRA CL E G H19093179ORPHA:586Cystic fibrosis3
HP:0045081HP:0031418Increased body mass index1FLT1 CL E G H23213763ORPHA:275555PreeclampsiaHP:0040283 - Occasional11
HP:0045081HP:0045082Decreased body mass index1GCLC CL E G H27294311ORPHA:586Cystic fibrosis2
HP:0045081HP:0045082Decreased body mass index1GSTM3 CL E G H29474635ORPHA:586Cystic fibrosis1
HP:0045081HP:0045082Decreased body mass index1HFE CL E G H30774886ORPHA:586Cystic fibrosis38
HP:0045081HP:0045082Decreased body mass index1HMOX1 CL E G H31625013ORPHA:586Cystic fibrosis3
HP:0045081HP:0045082Decreased body mass index1HTT CL E G H30644851ORPHA:399Huntington diseaseHP:0040283 - Occasional12
HP:0045081HP:0045082Decreased body mass index1KCNN4 CL E G H37836293ORPHA:586Cystic fibrosis3
HP:0045081HP:0045082Decreased body mass index1MIF CL E G H42827097ORPHA:586Cystic fibrosis1
HP:0045081HP:0045082Decreased body mass index1SERPINA1 CL E G H52658941ORPHA:586Cystic fibrosis131
HP:0045081HP:0045082Decreased body mass index1SLC11A1 CL E G H655610907ORPHA:586Cystic fibrosis2
HP:0045081HP:0045082Decreased body mass index1SLC16A2 CL E G H656710923ORPHA:59Allan-Herndon-Dudley syndromeHP:0040282 - Frequent57
HP:0045081HP:0045082Decreased body mass index1SLC25A13 CL E G H1016510983ORPHA:247585Citrullinemia type IIHP:0040281 - Very frequent82
HP:0045081HP:0045082Decreased body mass index1SLC26A9 CL E G H11501914469ORPHA:586Cystic fibrosis5
HP:0045081HP:0045082Decreased body mass index1SLC2A3 CL E G H651511007ORPHA:399Huntington diseaseHP:0040283 - Occasional1
HP:0045081HP:0045082Decreased body mass index1SLC6A14 CL E G H1125411047ORPHA:586Cystic fibrosis
HP:0045081HP:0045082Decreased body mass index1SLC9A3 CL E G H655011073ORPHA:586Cystic fibrosis7
HP:0045081HP:0031418Increased body mass index1STOX1 CL E G H21973623508ORPHA:275555PreeclampsiaHP:0040283 - Occasional2
HP:0045081HP:0045082Decreased body mass index1STX1A CL E G H680411433ORPHA:586Cystic fibrosis
HP:0045081HP:0045082Decreased body mass index1TGFB1 CL E G H704011766ORPHA:586Cystic fibrosis13
HP:0045081HP:0031418Increased body mass index1THOC2 CL E G H5718719073OMIM:300957Mental retardation, X-linked 12/35HP:0040284 - Very rare5
HP:0045081HP:0031418Increased body mass index1THRA CL E G H706711796OMIM:614450Hypothyroidism, congenital, nongoitrous, 6.9


Genes (28) :CEACAM3 CEACAM6 CFTR CLCA4 CORIN DCTN4 EDNRA FLT1 GCLC GSTM3 HFE HMOX1 HTT KCNN4 MIF SERPINA1 SLC11A1 SLC16A2 SLC25A13 SLC26A9 SLC2A3 SLC6A14 SLC9A3 STOX1 STX1A TGFB1 THOC2 THRA

Diseases (7) :ORPHA:586 ORPHA:275555 ORPHA:399 ORPHA:59 ORPHA:247585 OMIM:300957 OMIM:614450
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.